C O R R I G E N D U M
Open Forum Infectious Diseases
CORRIGENDUM • ofid • 1
Corrigendum to: Impact of the M184V/I Mutation on the
Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in
HIV Treatment-Experienced Patients
Flaminia Olearo,
1,a,Huyen Nguyen,
2,3,aFabrice Bonnet,
4,5Sabine Yerly,
6Gilles Wandeler,
7Marcel Stoeckle,
8Matthias Cavassini,
9Alexandra Scherrer,
2,3Dominique Costagliola,
10Patrick Schmid,
11Huldrych F Günthard,
2,3Enos Bernasconi,
12Jürg Boeni,
3Antonella D’Arminio Monforte,
13Maurizio Zazzi,
14Barbara Rossetti,
15Didier Neau,
5Pantxika Bellecave,
16Bart Rijnders,
17Peter Reiss,
17Ferdinand Wit,
17Roger Kouyos,
2,3,band Alexandra Calmy
1,b1Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Switzerland; 2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich,
Switzerland; 3Institute of Medical Virology, Swiss National Reference Centre for Retroviruses, University of Zurich, Switzerland; 4University of Bordeaux, Institut de Santé Publique d’Epidémiologie
et de Développement (ISPED), U1219 INSERM, France; 5Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, France; 6Laboratory of Virology,
Geneva University Hospitals and Faculty of Medicine, Switzerland; 7Institute of Social and Preventive Medicine, University Hospital of Bern, Switzerland; 8Division of Infectious Diseases, University
Hospital of Basel, Switzerland; 9Division of Infectious Diseases, Lausanne University Hospital, Switzerland; 10INSERM, Sorbonne Université, Institut Pierre Louis d’Épidémiologie et de Santé
Publique, Paris, France; 11Division of Infectious Diseases and Hospital Epidemiology, St. Gallen Cantonal Hospital, Switzerland; 12Division of Infectious Diseases, Ospedale Regionale di Lugano,
Switzerland; 13Department of Health Sciences, Institute of Infectious and Tropical Medicine, L’Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, University of Milan, Italy; 14Department
of Medical Biotechnology, University of Siena, Italy; 15Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy; 16Virology Laboratory, Centre Hospitalier Universitaire de
Bordeaux, France; 17Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands
In “Impact of the M184V/I Mutation on the Efficacy of Abacavir/
Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced
Patients” Open Forum Infectious Diseases, Volume 6, Issue 10,
October 2019, ofz330,
https://doi.org/10.1093/ofid/ofz330
, the
surname of a co-author, Dominique Costagliola, was misspelled.
This was corrected in the new version of the manuscript.
applyparastyle “fig//caption/p[1]” parastyle “FigCapt”
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com DOI: 10.1093/ofid/ofz500
Open Forum Infectious Diseases®